Skip to main content

Table 3 Multivariable logistic regression analysis for variables among three groups

From: The dynamic risk factors of cardiovascular disease among people living with HIV: a real-world data study

Effect

Group1(N=8938)

Group2(N=4255)

Group3(N=1592)

aOR

p-value

aOR

p-value

aOR

p-value

Age in 30-39 vs. 18-29

1.45 (1.1,1.92)

0.0084

2.02 (1.32,3.07)

0.0011

1.72 (0.85,3.48)

0.1338

Age in 40-49 vs. 18-29

2.48 (1.9,3.22)

<0.0001

3.16 (2.09,4.77)

<0.0001

3.22 (1.63,6.38)

0.0008

Age in 50-59 vs. 18-29

2.92 (2.19,3.91)

<0.0001

3.62 (2.2,5.96)

<0.0001

4.71(2.07,10.71)

0.0002

Age in >=60 vs. 18-29

5.05 (3.47,7.35)

<0.0001

8.68 (4.14,18.2)

<0.0001

3.56(0.82,15.41)

0.09

Male vs. Female

0.98 (0.78,1.24)

0.88

1.25 (0.85,1.83)

0.2601

1.21 (0.67,2.17)

0.5315

Black vs. White

0.89 (0.71,1.12)

0.3229

1.08 (0.75,1.56)

0.6862

0.71 (0.4,1.28)

0.2523

Hispanic and Other vs. White

0.7 (0.48,1.03)

0.0724

0.54 (0.22,1.37)

0.1978

0.71 (0.21,2.37)

0.5753

Urban vs. Rural

1.11 (0.89,1.39)

0.3451

1.22 (0.87,1.71)

0.2447

0.56 (0.29,1.08)

0.0851

Tobacco use Yes vs. No

1.64 (1.36,1.97)

<0.0001

1.68 (1.24,2.28)

0.0008

1.87 (1.11,3.16)

0.0185

Alcohol use Yes vs. No

1.16 (0.89,1.5)

0.2651

0.91 (0.62,1.33)

0.6224

1.17 (0.67,2.04)

0.5738

Hypertension Yes vs. No

2.1 (1.71,2.57)

<0.0001

2.12 (1.54,2.91)

<0.0001

2.52 (1.49,4.24)

0.0005

Dyslipidemia Yes vs. No

2.52 (1.85,3.42)

<0.0001

1.85 (1.25,2.74)

0.0022

1.26 (0.69,2.31)

0.4532

Obesity Yes vs. No

1.83 (1.36,2.46)

<0.0001

1.59 (1.07,2.37)

0.0226

2.01 (1.14,3.55)

0.0163

Diabetes Mellitus Yes vs. No

1.52 (1.16,1.99)

0.0021

2.09 (1.45,3)

<0.0001

1.21 (0.67,2.2)

0.5262

Chronic Kidney Disease Yes vs. No

3.13 (2.41,4.07)

<0.0001

2.19 (1.51,3.17)

<0.0001

2.36 (1.29,4.28)

0.005

Family history of CVD Yes vs. No

1.71 (1.12,2.62)

0.0134

2.85 (1.34,6.09)

0.0067

——

——

Injecting Drug Use vs. Heterosexual

1.38 (0.95,2)

0.0939

0.95 (0.51,1.76)

0.8648

0.7 (0.24,2.01)

0.5061

MSM vs. Heterosexual

0.94 (0.7,1.24)

0.6446

1.09 (0.71,1.68)

0.6869

0.61 (0.3,1.24)

0.173

Other transmission modes vs. Heterosexual

0.94 (0.73,1.2)

0.6191

0.94 (0.63,1.39)

0.7488

1.16 (0.65,2.07)

0.6111

First cd4 counts (cells/mm3) 200-350 vs. <200

1.23 (0.92,1.63)

0.1643

0.88 (0.53,1.44)

0.6058

1.16 (0.48,2.83)

0.7379

First cd4 counts (cells/mm3) >350 vs. <200

1.28 (0.95,1.72)

0.1054

0.83 (0.49,1.42)

0.4998

0.64 (0.23,1.79)

0.3972

Initial cd4 counts (cells/mm3) 200-350 vs. <200

——

——

1.19 (0.79,1.79)

0.4085

0.62 (0.3,1.25)

0.1788

Initial cd4 counts (cells/mm3) >350 vs. <200

——

——

1.15 (0.77,1.7)

0.4996

0.81 (0.44,1.49)

0.5003

Recent cd4 counts (cells/mm3) 200-350 vs. <200

0.36 (0.27,0.47)

<0.0001

0.34 (0.21,0.56)

<0.0001

0.34 (0.14,0.84)

0.0195

Recent cd4 counts (cells/mm3) >350 vs. <200

0.22 (0.17,0.3)

<0.0001

0.18 (0.11,0.29)

<0.0001

0.25 (0.1,0.6)

0.0019

% of days with low cd4 counts 26-70% vs. 0-25%

1.02 (0.78,1.35)

0.8673

0.81 (0.53,1.24)

0.3392

0.69 (0.34,1.41)

0.3056

% of days with low cd4 counts 71-100% vs. 0-25%

0.92 (0.67,1.27)

0.6208

0.17 (0.08,0.38)

<0.0001

——

——

% of days with viral suppression 21-50% vs. 0-20%

0.44 (0.34,0.57)

<0.0001

0.5 (0.33,0.74)

0.0007

1.42 (0.73,2.77)

0.3044

% of days with viral suppression 51-100% vs. 0-20%

0.27 (0.21,0.34)

<0.0001

0.51 (0.35,0.75)

0.0006

1.16 (0.65,2.08)

0.6239

AIDS at HIV diagnosis Yes vs. No

1.33 (1.04,1.69)

0.0234

0.93 (0.63,1.38)

0.7135

0.44 (0.21,0.92)

0.0288

HIV diagnosis year

1 (0.97,1.02)

0.6538

0.8 (0.76,0.85)

<0.0001

0.55 (0.45,0.67)

<0.0001

% of years in retention in care 31-75% vs. 0-30%

0.52 (0.39,0.69)

<0.0001

0.57 (0.36,0.9)

0.017

0.24 (0.09,0.6)

0.0026

% of years in retention in care 76-100% vs. 0-30%

0.86 (0.68,1.1)

0.2371

0.93 (0.64,1.36)

0.7215

0.85 (0.43,1.66)

0.6287

Timely linkage to care Yes vs. No

1.33 (1.09,1.61)

0.0047

1 (0.75,1.33)

0.9866

1.41 (0.87,2.29)

0.1601

  1. Note: For model corresponding to group1, only the variable first CD4 counts was remained due to the equality between initial CD4 counts and first CD4 counts. In addition, because there are no individuals belonging to the level of 71-100% for variable percent of low CD4 counts in group 3, the level is not included in the corresponding model